• Home
  • NEW DAY MEDICINE
  • 11 (49) 2022
  • 110 -11 (49) 2022 — Ermekbaeva A.U., Kamilova U.K. — STUDY OF ENDOTHELIAL FUNCTION IN PATIENTS WITH CARDIORESPIRATORY DISEASES AFTER COVID-19

110 -11 (49) 2022 — Ermekbaeva A.U., Kamilova U.K. — STUDY OF ENDOTHELIAL FUNCTION IN PATIENTS WITH CARDIORESPIRATORY DISEASES AFTER COVID-19

STUDY OF ENDOTHELIAL FUNCTION IN PATIENTS WITH CARDIORESPIRATORY DISEASES AFTER COVID-19

Ermekbaeva A.U., Tashkent Medical Academy, Uzbekistan

Kamilova U.K. Tashkent Medical Academy, Uzbekistan

Resume

In patients with cardiorespiratory diseases who underwent COVID-19, diseases of the cardiovascular system were most common, endothelial dysfunction was most pronounced in patients with comorbid infections.

Keywords: COVID-19, endothelial function, cardiorespiratory system

First page

643

Last page

646

For citation: Ermekbaeva A.U., Kamilova U.K. – STUDY OF ENDOTHELIAL FUNCTION IN PATIENTS WITH CARDIORESPIRATORY DISEASES AFTER COVID-19 //New Day in Medicine 11(49)2022 643-646 https://clck.ru/32vgTh

LIST OF REFERENCES:

  1. Ackermann M., Verleden S.E., Kuehnel M., Haverich A., Welte T., Laenger F., Vanstapel A., Werlein C., Stark H., Tzankov A., Li W.W., Li V.W., Mentzer S.J., Jonigk D. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. //N Engl J Med. 2020 Jul 9;383(2):120-128. doi: 10.1056/NEJMoa2015432.
  2. Arutyunov G.P., Tarlovskaya E.I., Arutyunov A.G.  et al., [ACTIV SARS-CoV-2 registry (Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients). Assessment of impact of combined original comorbid diseases in patients with COVID-19 on the prognosis]. Ter Arkh. 2022 Jan 15;94(1):32-47. Russian. doi: 10.26442/00403660.2022.01.201320. PMID: 36286918.
  3. Arutyunov G.P., Tarlovskaya E.I., Arutyunov A.G., Belenkov Y.N. et al., [International register “Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients (ACTIV SARS-CoV-2)”]. Kardiologiia. 2021 Jan 12;60(11):30-34. Russian. PMID: 33487147.
  4. Chaturvedi S., Gorelick P. The interplay between COVID 19 and non-communicable diseases. J Stroke Cerebrovasc Dis. 2020 Sep; 29(9):105104. doi: 10.1016/j.jstrokecerebrovasdis.2020.105104.
  5. Escher R., Breakey N., Lämmle B. Severe COVID-19 infection associated with endothelial activation. Thromb Res. 2020 Jun;190:62. doi: 10.1016/j.thromres.2020.04.014.
  6. Escher R., Breakey N., Lämmle B. ADAMTS13 activity, von Willebrand factor, factor VIII and D-dimers in COVID-19 inpatients. Thromb Res. 2020 Aug;192:174-175. doi: 10.1016/j.thromres.2020.05.032.
  7. Gambardella J., Santulli G. What is linking COVID-19 and endothelial dysfunction? Updates on nanomedicine and bioengineering from the 2020 AHA Scientific Sessions. //Eur Heart J Cardiovasc Pharmacother. 2021 May 23;7(3):e2-e3.
  8. Gold M.S., Sehayek D., Gabrielli S., Zhang X., McCusker C., Ben-Shoshan M. COVID-19 and comorbidities: a systematic review and meta-analysis. //Postgrad Med. 2020 Nov;132(8):749-755. doi: 10.1080/00325481.2020.1786964.
  9. Grobler C., Maphumulo S.C., Grobbelaar L.M., Bredenkamp J.C., Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes. Int J Mol Sci. 2020 Jul 21;21(14):5168. doi: 10.3390/ijms21145168.
  10. Iba T., Connors J.M., Levy J.H. The coagulopathy, endotheliopathy, and vasculitis of COVID-19. Inflamm Res. 2020 Dec;69(12):1181-1189. doi: 10.1007/s00011-020-01401-6.
  11. Karacaer C., Yaylaci S., Demirci T., Cekic D., Suner K.O., Cokluk E., Varim C. Association of mortality and endothelial dysfunction with serum ADMA level in COVID-19 patients. //Pak J Med Sci. 2022 Sep-Oct;38(7):1808-1815. doi: 10.12669/pjms.38.7.5327.
  12. Kumar A., Narayan R.K., Kumari C., Faiq M.A., Kulandhasamy M., Kant K., Pareek V. SARS-CoV-2 cell entry receptor ACE2 mediated endothelial dysfunction leads to vascular thrombosis in COVID-19 patients. Med Hypotheses. 2020 Dec;145:110320. doi: 10.1016/j.mehy.2020.110320.
  13. Subramaniam S., Kothari H., Bosmann M. Tissue factor in COVID-19-associated coagulopathy. Thromb Res. 2022 Dec;220:35-47. doi: 10.1016/j.thromres.2022.09.025.
  14. ., Tecson K.M., McCullough P.A. Endothelial dysfunction contributes to COVID-19-associated vascular inflammation and coagulopathy. //Rev Cardiovasc Med. 2020 Sep 30; 21(3):315-319. doi: 10.31083/j.rcm.2020.03.126.

file

download